Luke Rosiak @lukerosiak
It says revenue might shrink this year because of lower "compliance" in taking the vaccine--but, interestingly enough, this will have a negligible effect on the number of people who get symptomatic COVID, to whom it can sell oral treatments. — PolitiTweet.org